– James F. Taulman, former Editor-in-Chief of the first independently licensed website to offer stock reports and services based on the CAN SLIM® investment system.
6:45 AM – MORNING MARKET UPDATE & WATCH LIST
NOTE: Today’s watch list can be found here.
[dropcap]O[/dropcap]n Wednesday, the Dow Jones closed -0.4% lower, while the S&P 500 and the Nasdaq finished flat.
QUOTE OF THE DAY:
“Sometimes life will test you but remember this: When you walk up a mountain, your legs get stronger.”
– Unknown
This morning, US stock futures are pointing modestly lower.
European markets were up, while equities in Asia ended the session mostly lower.
____________________________________________________
Now You Can Start Receiving James’ –
Technical SetUps WatchList Each Market Morning
Early each market morning James diligently screens through hundreds of high EPS and RS ranked stocks that have solid fundamentals.
He is looking for those select few which are setting up in sound technical bases and which looked poised to breakout that day.
Each stock is listed with specific trading criteria such as a TRIGGER PRICE, TRIGGER VOLUME and MAX BUY PRICE.
Normally $19.95 a month, now just $9 a month through James’ BuyingBreakOuts.com website.
LEARN MORE ABOUT THIS SPECIAL 50% DISCOUNT OFFER HERE
____________________________________________________
Blackstone (BX) and Philip Morris International (PM) plan to release earnings before the open Thursday. American Express (AXP), E*TRADE (ETFC) and PayPal (PYPL) will follow after the close.
In case you missed it, there is the special report I put together after the market pulled back last week – “High-Ranked Pullbacks to Support” (available to everyone).
I ran my routine stock screens early this morning, yet did not find any new stocks to add to our watch list.
I removed ICLR as the stock pulled back with the market last week, and now just does not have a proper base to buy off of.
We now have 7 stocks which we will be watching for the next buyable breakout – see here.
One in particular is GMED which has been recovering from the markets uburpt pullback last week. This Medical-Products leader is now within -4% of its TRIGGER PRICE.
This selection was also included in a special report I put out over the weekend – “High-Ranked Pullbacks to Support” and is now up +7.35% since.
Chart courtesy of stockcharts.com.
Read more about Globus Medical Inc. from IBD and see some of the stock’s ranks here.
Now get access all watch lists with updated trading criteria including – TRIGGER PRICE, TRIGGER VOLUME, and MAX BUY PRICE for every stock here.
Missed any of these morning reports? You can find all previous reports here.
Standard rules apply – any gains above the stock’s TRIGGER PRICE while the day’s volume is at least on pace to make the TRIGGER VOLUME would have any of these set ups confirming a BUY signal up to their MAX BUY PRICE by default.
Keep in mind that when a stock breaks out – becomes potentially buyable – there are other factors to consider.
Volume on the breakout. A stock that is breaking out through resistance, with an increase in volume of +50% above the stock’s average volume (50 DAV), is showing more conviction and more demand. This is not saying – all lower volume breakouts will fail. Actually, we’ve seen many continue higher. If you have found that you did buy a stock that showed lower daily volume or volume under 50%, going forward – simply treat it a regular trade.
Earnings BreakOuts. Many stocks from our watch list will break out during earnings season. Earnings breakouts can be more rewarding, however, these trades carry much more risk then traditional (non-news) breakouts. One needs to also consider – the strength/weakness of the fundamental news that was just released along with the forward-looking guidance the company gave, investors response to the conference call, etc. For anyone who is not familiar with – buying earnings breakouts – I suggest that they sit through a few seasons to study, paper trade, and show some profits, before applying actual capital.
As always, if anyone has any questions – please feel free to email me at james@jamestaulman.com as I would be glad to assist you.
_________________________________________________
About the Founder: 
James F. Taulman – James served as Editor-in-Chief of the first independently licensed website that offered stock reports and services based on the CAN SLIM® investment system. He has developed a knack for being able to quickly and accurately analyze high-ranked stocks based on this winning investment strategy. Over the years, Mr. Taulman has enjoyed assisting individuals from professional money managers to private investors with their needs in relation to implementing this investment approach on a daily basis in the current marketplace. Each Sunday you could hear him deliver his weekly market report as part of the “Your Money Matters” radio program on ABC and CBS radio networks. _________________________________________________ Disclaimer: James Taulman is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The independent contractors and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company’s website, or in its publications, are made as of the date stated and are subject to change without notice. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company’s products (collectively, the “Information”) are provided for informational and educational purposes only and should not be construed as investment advice.